Revolution Medicines competitors

Revolution Medicines's competitors include Rapid Micro Biosystems, Ra Pharmaceuticals, LGC Biosearch Technologies and Loxo Oncology
Add company...
Revolution Medicines
REVOLUTION Medicines is redesigning evolution's products to treat serious diseases. The company discovers and develops new drugs by deploying our innovative product engine to reconfigure substances that are inherently rich with biological function as a result of natural selection.
Rapid Micro Biosystems
Rapid Micro Biosystems offers tools that detect microbial contamination in manufacturing pharmaceutical, biotechnology and other products.
Ra Pharmaceuticals
Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.
LGC Biosearch Technologies
LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
Founding Date
Founding Date
2015
Founding Date
2006
Founding Date
2008
Founding Date
1842
Founding Date
2013
Type
Type
Private
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Redwood City, US HQ
Locations
Lowell, US HQ
Freising, DE
Locations
Cambridge, US HQ
Locations
Teddington, GB HQ
Locations
Stamford, US HQ
South San Francisco, US
Employees
Employees
629% increase
Employees
982% decrease
Employees
46
Employees
N/A
Employees
4757% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
341.5 m
Valuation ($)
N/A
Valuation ($)
4.8 b
Twitter followers
Twitter followers
N/A
Twitter followers
447
Twitter followers
N/A
Twitter followers
2.4 k
Twitter followers
46

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($54.4m) (FY, 2017)
Net income
(£4.3m) (FY, 2017)
Net income
($72.4m) (FY, 2016)

Funding

Latest funding round
Latest funding round
$ 25m (over 1 year ago)
Latest funding round
$ 60m (4 months ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 70m
Total funding raised
$ 157.4m
Total funding raised
$ 77.4m
Total funding raised
N/A
Total funding raised
$ 57m
For sources of this data, please see the company profileDownload Excel

View company profiles

Rapid Micro Biosystems
HQ
Lowell, US
Employees
98↓ 2% decrease

Rapid Micro Biosystems offers tools that detect microbial contamination in manufacturing pharmaceutical, biotechnology and other products.

View company
Ra Pharmaceuticals
HQ
Cambridge, US
Employees
46

Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.

View company
LGC Biosearch Technologies
HQ
Teddington, GB

LGC is an international leader in the laboratory services, measurement standards, reference materials, genomics and proficiency testing marketplaces.

View company
Loxo Oncology
HQ
Stamford, US
Employees
47

Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.

View company